| Literature DB >> 20352221 |
Abstract
Menstrual disorders associated with the use of TNF alpha blocker have been rarely reported. Herein, we reported two cases aged 31 and 41, presenting with excessive menstrual bleeding occured after adalimumab administration which was subsequently discontinued.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20352221 DOI： 10.1007/s00296-010-1455-9
Source DB: PubMed Journal: Rheumatol Int ISSN： 0172-8172 Impact factor: 2.631